Scientists uncover how a rogue protein weakens the gut's protective shield

Scientists have uncovered a key molecular player in the breakdown of the gut barrier, a process linked to serious metabolic diseases. The protein Angptl4 appears to weaken the gut’s protective lining, particularly in conditions like Metabolic Dysfunction-Associated Steatohepatitis (MASH). This discovery could pave the way for new treatments and early detection methods. The study focused on Angiopoietin-like 4 (Angptl4), a protein that responds to both diet and gut bacteria. When activated by high-fat foods or an imbalance in gut microbes, Angptl4 triggers a chain reaction. It destabilises tight junction proteins—such as occludin and claudin—which normally seal the gaps between cells in the gut lining.

A leaky gut barrier allows harmful substances to enter the bloodstream, worsening inflammation and liver damage. In mouse models of MASH, removing Angptl4 from the gut’s epithelial cells strengthened the barrier and reduced liver fibrosis. The protein also activates the NF-κB pathway, further weakening the gut’s defences.

Modern diets, heavy in processed and fatty foods, may unintentionally boost Angptl4 levels. Gut bacteria play a role too, producing metabolites like short-chain fatty acids that influence how much Angptl4 the body makes. This creates a direct link between what we eat, our gut microbes, and the health of the gut barrier. The findings highlight Angptl4 as a potential target for therapies aimed at restoring gut barrier function. Early detection of MASH and related diseases could also improve through biomarkers based on Angptl4 levels. Researchers now have a clearer path to developing treatments that address the root causes of metabolic disorders tied to gut health.